Myeloid Leukemia, Philadelphia-Positive

Myeloid Leukemia, Philadelphia-Positive — Trials · CancerIndex

Clinical trials

Registered studies

17 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 7
Recruiting: 3
Ph III recruiting: 1
Growth YoY: —
Industry share: 43%
Top sponsor: M.D. Anderson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03241199	The Efficacy and Safety of Induction-Maintenance Protocol for Patients With Chronic Myelogenous Leukaemia	unknown	Phase 2	15	The University of Hong KongOTHER	1	Aug 8, 2017	clinicaltrials
NCT00966810	Allogeneic Stem Cell Transplantation in CML With Partial T Cell Depletion	unknown	Phase 2 / Phase 3	40	Rambam Health Care CampusOTHER	1	Aug 27, 2009	clinicaltrials